HSR&D Citation Abstract
Search | Search by Center | Search by Source | Keywords in Title
Jia X, Akeroyd JM, Nasir K, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 Mar 5; 139(10):1341-1343.
No abstract provided for this citation.